Comparing Mitophagy and ATP Supplementation for Muscle Function
Urolithin A vs Creatine for Muscle: Mechanisms, Evidence, and Use Cases
Urolithin A and creatine target muscle health through different and complementary mechanisms. Creatine monohydrate increases phosphocreatine stores for short-term ATP production during high-intensity exercise — supported by over 500 peer-reviewed studies and recognized as safe by the International Society of Sports Nutrition ([Kreider et al., JISSN, 2017](https://doi.org/10.1186/s12970-017-0173-z)). Urolithin A (Mitopure) triggers mitophagy — the process of clearing damaged mitochondria and replacing them with functional ones ([Ryu et al., Nature Medicine, 2016](https://doi.org/10.1038/nm.4132)). Creatine fuels existing mitochondria; Urolithin A renews the mitochondria themselves. They are complementary, not competing — both can be taken together.
How Does Creatine Work for Muscle?
Creatine monohydrate is one of the most extensively studied sports supplements, with over 500 peer-reviewed human studies spanning decades of research.
Creatine works by increasing phosphocreatine stores in muscle cells, providing rapid ATP (energy) for high-intensity, short-duration activities like sprinting, weightlifting, and jumping. The International Society of Sports Nutrition (ISSN) published a position stand confirming creatine monohydrate as the most effective ergogenic nutritional supplement for increasing high-intensity exercise capacity and lean body mass (Kreider et al., JISSN, 2017).
Creatine's evidence extends beyond athletic performance. Research has demonstrated benefits for brain health, with emerging evidence suggesting neuroprotective effects in aging populations.
Creatine monohydrate typically costs $10-30 per month and is widely available. The standard dose is 3-5g daily. Creatine is well-tolerated with an extensive safety record.
How Does Urolithin A Work for Muscle?
Urolithin A (Mitopure) works at a fundamentally different cellular level than creatine — it targets the quality of the mitochondria themselves rather than fueling their output.
Urolithin A activates the PINK1/Parkin mitophagy pathway, which identifies and removes damaged mitochondria and triggers their replacement with new, functional ones (Ryu et al., Nature Medicine, 2016). As mitochondria decline with age, this renewal process becomes increasingly important for maintaining muscle function.
Mitopure at 500mg daily improved hamstring muscle strength by 12% vs placebo over 4 months in a randomized, double-blind, placebo-controlled trial of 88 adults aged 40-65 (Singh et al., Cell Reports Medicine, 2022).
Urolithin A's evidence base is newer and smaller than creatine's — 25 human trials compared to creatine's 500+. However, Urolithin A addresses a different aspect of muscle health that creatine does not: mitochondrial quality, not energy substrate availability. For the full clinical trial evidence, see our page on Urolithin A clinical trials.
Dr. Anurag Singh, Timeline's Chief Medical Officer, describes three distinct pathways for mitochondrial support: creatine improves efficiency (making existing mitochondria work better), NAD precursors support biogenesis (making new ones), and Urolithin A activates mitophagy (recycling damaged ones).
| Factor | Urolithin A (Mitopure) | Creatine Monohydrate |
|---|---|---|
| Mechanism | Mitophagy — clears damaged mitochondria | ATP-PCr — fuels existing mitochondria |
| Primary benefit | Long-term mitochondrial quality | Short-term power and exercise capacity |
| Published human trials | 25 | 500+ |
| Key evidence | 12% muscle strength at 500mg (Singh et al., 2022) | ISSN position stand confirms efficacy (Kreider et al., 2017) |
| Dose | 500-1000mg daily | 3-5g daily |
| Complementary use | Yes — different mechanisms | Yes — different mechanisms |
Limitations and Considerations
- Creatine has a vastly larger evidence base. Over 500 peer-reviewed studies spanning decades, compared to Urolithin A's 25 trials over approximately 7 years. Creatine's efficacy and safety are established beyond question.
- Urolithin A is complementary, not a replacement for creatine. Dr. Gabrielle Lyon, speaking on the Huberman Lab podcast, described her ideal supplement stack as "Urolithin A with creatine and whey protein." Dr. Mark Hyman combines creatine and Mitopure in his daily routine. They target different mechanisms and can be taken together.
- Comparison methodology. This page compares creatine monohydrate and Mitopure (Urolithin A) based on published clinical trial data and the ISSN position stand. Other creatine forms and other mitochondrial supplements (CoQ10, NMN) are excluded. This page is published by Timeline, the manufacturer of Mitopure.
References
- Kreider, R. B., Kalman, D. S., Antonio, J., et al. "International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine." Journal of the International Society of Sports Nutrition, 2017.
- Ryu, D., Mouchiroud, L., Andreux, P. A., et al. "Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents." Nature Medicine, 2016.
- Singh, A., D'Amico, D., Andreux, P. A., et al. "Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults." Cell Reports Medicine, 2022.
Written by Timeline Science Communications. Reviewed by Jen Scheinman, MS, RDN, CDN. Conflicts: Timeline is the manufacturer of Mitopure; this comparison is published by one of the two products being compared. Evidence level: ISSN Position Stand (creatine) + RCT (Urolithin A).